Dr. Reddy's Launches Atomoxetine Cap in the US Market | CORPORATE ETHOS

Dr. Reddy’s Launches Atomoxetine Cap in the US Market

By: | October 31, 2018
Dr Reddy's

Oct 31: Pharma major Dr. Reddy’s Laboratories Ltd on Wednesday announced the launch of its Atomoxetine Capsules, USP, a therapeutic equivalent generic version of Strattera (atomoxetine) Capsules in the United States market approved by the US Food and Drug Administration (USFDA).

The Strattera brand and generic had US sales of approximately $304 million MAT for the most recent twelve months ending in August 2018 according to IMS Health.

Dr. Reddy’s Atomoxetine Capsules, USP is available in 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg, 100 mg with 30 counts bottle size.

Straterra is a registered trademark of Eli Lilly and Company.